RSM US LLP

The 2025 holiday season highlighted how quickly #AI is becoming embedded across the #ConsumerGoods landscape.   From product discovery and customer service to demand planning and inventory decisions, brands are using AI to improve efficiency and create more personalized experiences.   AI is no longer a differentiator. Companies that operationalize AI across discovery, service and fit experiences may be better positioned to strengthen margins, build customer loyalty and adapt to changing market conditions.   Explore the latest insights from @RSM US LLP: https://rsm.us/4uTbAOM

As we enter our second century, we’re continuing to invest in the future of our business and the clients we serve. Today, we’re announcing the formation of a dedicated corporate development function and the appointment of Don Lipari to lead this new effort. With more than 30 years of leadership experience at RSM, Don will help drive strategic growth opportunities across acquisitions, partnerships, joint ventures and new market expansion. This new function reflects both our scale and our ambition as we build on 100 years of serving #MiddleMarket businesses. Read more: https://rsm.us/4vWXOMJ

Clinical trial timelines are beginning to diverge more meaningfully across global markets. In the U.S., AI adoption, decentralized trial models and evolving FDA guidance are helping compress timelines and improve operational efficiency. In the UK, trial timelines continue to lengthen as organizations navigate infrastructure constraints, setup delays and operational complexity across the NHS environment. These differences are starting to influence: • Funding strategy  • Capital planning  • Trial geography decisions  • Investor confidence  • Commercialization timing In RSM US LLP's latest #LifeSciences industry outlook myself and Max Stanyard explore why execution predictability is becoming increasingly important for #Biopharma companies operating across both markets. https://rsm.us/4amx0N4 

#Cybersecurity conversations are changing quickly in the middle market.   The challenge is no longer just protecting infrastructure. Organizations are now trying to balance:   • AI adoption • Identity and access risks • Economic pressure on budgets • Increasingly sophisticated threat activity   One of the more interesting findings in the latest RSM US LLP MMBI Cybersecurity 2026 report is where companies are focusing their cybersecurity efforts.   Detection and response, cloud security and risk management continue to lead investment priorities. At the same time, identity risks and AI governance are becoming much more important.   The report includes valuable perspective on where middle market firms are investing, where gaps still exist and how leaders are adapting their cyber strategies.   Read the full report: https://rsm.us/4esXWx6

Our people do meaningful work every day and we love when they get to share it with the ones cheering them on at home. At RSM, we are proud of the opportunities that bring families into our offices and our teams together. See some of our favorite moments below! https://rsm.us/4uSxvpm #GrowForwardatRSM

The #medtech innovation landscape is shifting.   Private and mid-cap companies are driving a larger share of clinical trials and device approvals, while large-cap firms continue increasing R&D spend with fewer approvals reaching market.   A few themes shaping the sector right now:   • Capital efficiency matters more • Strategic trials are becoming a competitive advantage • Regulatory complexity is reshaping development decisions • AI-enabled devices are increasing commercialization costs   The next wave of medtech growth may look very different than the last.   More in RSM US LLP’s latest #LifeSciences industry outlook: https://rsm.us/4v0ufJl

Celebrating 100 years of RSM US LLP last week in Las Vegas was a powerful reminder of what has always set this firm apart: our people.   Each Owners Meeting, we invite 200 “FutureMakers” to join alongside our owners. The FutureMakers, managers from across the firm, take part in conversations about where we are headed and what it will take to lead into the next decade and beyond. You could feel the energy and excitement they brought into the room.   On our final morning, I had the opportunity to spend time on stage with three of these future leaders: Etana Flegenheimer, Jonathan Entler, CPA and Mark Black. What stood out was how clearly they see what matters. They spoke about:   - the importance of building real, personal connections at every level - embracing technology in ways that strengthen how we work - staying focused on what has always been core to our success—our clients and our people   It is a powerful combination of consistency and evolution.   The next chapter of RSM will be shaped by leaders like these who are curious, thoughtful and ready to lead with purpose. I cannot wait to see the future they make. #GrowForwardatRSM